In a rare procedure involving four patients, a surgical team at NewYork-Presbyterian/Columbia completed a first-of-its-kind transplant in which a recipient got a new liver from a living donor, and their original liver was split to help two people.
Xenotransplantation is inching closer to clinical reality at Columbia, where decades of work in immune tolerance are converging to make lifesaving pig-to-human organ transplants possible.
When a West Point graduate’s wife faced a rare, life-threatening cancer, it was a fellow alum—now a pioneering liver surgeon at Columbia—who stepped in to save her life.
Dr. Michel Sadelain, a pioneer of CAR T-cell therapy, is leading Columbia’s new initiative to expand the use of genetically engineered “living drugs” beyond cancer and into fields like autoimmunity and organ transplantation.
Groundbreaking research at Columbia is bringing the field of transplantation closer to eliminating lifelong immunosuppression, transforming the future for patients.
In a series of videos, leaders in lung, liver, heart, and kidney discuss a new Columbia initiative that brings every transplant division together through collaboration, research, and support.
Dr. Jason Hawksworth is one of the few surgeons in the U.S. doing complex liver surgery entirely on the robot. In this interview, he shares his passion for robotic surgery and plans for the future.
